Lv3
312 积分 2022-02-22 加入
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
2个月前
已完结
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
2个月前
已完结
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
3个月前
已完结
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
4个月前
已完结
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
4个月前
已完结
Targeted therapy in advanced BRAF -mutated colorectal cancer: systematic review and network meta-analysis
5个月前
已完结
Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLC
5个月前
已完结
BRAF — a tumour-agnostic drug target with lineage-specific dependencies
5个月前
已完结
慢性便秘基层诊疗指南（2019年）
9个月前
已完结
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
9个月前
已完结
皖公网安备34019202002308
